A citation-based method for searching scientific literature

Thomas Powles, Joseph Paul Eder, Gregg D Fine, Fadi S Braiteh, Yohann Loriot, Cristina Cruz, Joaquim Bellmunt, Howard A Burris, Daniel P Petrylak, Siew-leng Teng, Xiaodong Shen, Zachary Boyd, Priti S Hegde, Daniel S Chen, Nicholas J Vogelzang. Nature 2014
Times Cited: 1709



Robert J Motzer, Bernard Escudier, David F McDermott, Saby George, Hans J Hammers, Sandhya Srinivas, Scott S Tykodi, Jeffrey A Sosman, Giuseppe Procopio, Elizabeth R Plimack, Daniel Castellano, Toni K Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas C Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S Simon, Li-An Xu, Ian M Waxman, Padmanee Sharma. N Engl J Med 2015
Times Cited: 3753




List of shared articles



Times cited

Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab.
Ana-Marija Grisic, Wenyuan Xiong, Lénaïg Tanneau, Siv Jönsson, Lena E Friberg, Mats O Karlsson, Haiqing Dai, Jenny Zheng, Pascal Girard, Akash Khandelwal. Clin Cancer Res 2022
0

The clinical and prognostic significance of CMTM6/PD-L1 in oncology.
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani. Clin Transl Oncol 2022
0

CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.
Minglu Xiao, Luoyingzi Xie, Guoshuai Cao, Shun Lei, Pengcheng Wang, Zhengping Wei, Yuan Luo, Jingyi Fang, Xingxing Yang, Qizhao Huang,[...]. J Immunother Cancer 2022
0

News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors.
Ombretta Melaiu, Valeria Lucarini, Roberto Giovannoni, Doriana Fruci, Federica Gemignani. Semin Cancer Biol 2022
21

CMTM6 as a master regulator of PD-L1.
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani. Cancer Immunol Immunother 2022
2

Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis.
Qi Jiang, Jinsheng Huang, Bei Zhang, Xujia Li, Xiuxing Chen, Bokang Cui, Shengping Li, Guifang Guo. Front Immunol 2022
0

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.
Lingdi Zhao, Tiepeng Li, Yongping Song, Yonghao Yang, Baozhen Ma, Yong Zhang, Yiman Shang, Benling Xu, Jindong Guo, Peng Qin,[...]. Front Immunol 2022
1